Elsevier

International Journal of Cardiology

Volume 250, 1 January 2018, Pages 233-239
International Journal of Cardiology

Bilateral sphenopalatine ganglion block reduces blood pressure in never treated patients with essential hypertension. A randomized controlled single-blinded study

https://doi.org/10.1016/j.ijcard.2017.10.042Get rights and content

Abstract

Background

Sympathetic fibers connect sphenopalatine ganglion (SPG) with the central nervous system. We aimed to study the effect of SPG block in blood pressure (BP) in never treated patients with stage I-II essential hypertension.

Methods

We performed bilateral SPG block with lidocaine 2% in 33 hypertensive patients (mean age 48 ± 12 years, 24 men) and a sham operation with water for injection in 11 patients who served as the control group (mean age 51 ± 12 years, 8 men). All patients have been subjected to 24 h ambulatory blood pressure monitoring prior and a month after the SBG block in order to estimate any differences in blood pressure parameters. We defined as responders to SBG block those patients with a 24 h SBP decrease ≥ 5 mm Hg.

Results

We found that 24 h and daytime DBP (p = 0.02) as well as daytime DBP load (p = 0.03) were decreased in the study group a month after SPG block. In addition, a significant response was noted in 12/33 responders (36%) regarding: a. SBP and DBP during overall 24 h and daytime (p < 0.001) and night-time periods, b. pre-awake and early morning SBP and c. SBP (daytime and night-time) and DBP (daytime) load. No differences regarding BP were found in the sham operation group.

Conclusions

SPG block is a promising, minimally invasive option of BP decrease in hypertensives, probably through SNS modulation. Additionally, due to its anesthetic effect, SPG block might act as a method of selection for those hypertensive patients with an activated SNS before any other invasive antihypertensive procedure.

Introduction

Arterial hypertension is associated with increased cardiovascular (CV) risk. While highly effective medical treatments exist, a substantial proportion of hypertensive patients remains inadequately controlled. The high prevalence and the subsequent complications of arterial hypertension along with difficulties in treatment and the limitations of pharmacological options led to the development of interventional approaches [1]. Sympathetic nervous system (SNS) acts as one of the main pathophysiological mechanisms which lead to arterial hypertension onset as well as to its maintenance [1], [2]. SNS blockage was a therapeutic target in hypertension disease in the past through surgical sympathectomy, nowadays we use beta blockers while in the near future invasive techniques like renal denervation are expected to be implemented in selected cases [3]. The minimal invasive procedure of SNS modulation through sphenopalatine ganglion (SPG) block follows the same track of therapeutic choices regarding arterial hypertension.

SPG block by topical anesthesia is currently indicated in the management of medically resistant cluster headaches, migraine, other trigeminal autonomic cephalalgias, postdural puncture headache as well as intractable orofacial pain syndromes [4], [5], [6], [7]. SPG is located in the cranial section of the autonomous nervous system; it is connected with the brain stem and the central nervous system (CNS) and bears unique characteristics favorable for the treatment of many painful syndromes involving the face and head [8], [9].

In a previous study, we hypothesized that SPG block through sympathetic nerves anesthesia might have resulted in blood pressure (BP) decrease. Indeed, that first study showed impressive results a month after the procedure in newly diagnosed and never treated hypertensive patients [10]. Blood pressure parameters were decreased in 24 h ambulatory blood pressure measurements (ABPM), especially in the group called responders (patients with 24 h average systolic BP decrease ≥ 5 mm Hg). However, that study was smaller and it did not include a control group.

The purpose of the present study is to re-examine the role of SPG block technique in BP parameters using ABPM in recently diagnosed and never treated middle-aged patients with mild to moderate essential hypertension compared to a control group of hypertensive patients in whom a sham operation of SPG block was applied.

Section snippets

Study population

We studied 44 Caucasian hypertensive patients visiting our outpatient clinic with recently diagnosed and never-treated stage I–II essential hypertension according to the 2013 guidelines of the European Society of Hypertension [1]. All patients were subjected to the following examinations within 2 weeks: 1) Three (3) office BP measurements in each one of the 3 subsequent visits in the hypertension outpatient clinic; 2) blood and urine sampling for routine blood chemistry (lipid profile included)

Statistical analysis

Unpaired and Paired Student t-test were used in order to compare numeric differences between the study group, the responders and the control group at baseline evaluation and any differences regarding BP parameters in each group separately before and after the SPG infiltration. All variables are expressed as mean ± standard deviation. Mann-Whitney test was used to compare categorical variables between groups. The level of statistical significance was determined as two-sided p < 0.05. Statistical

Results

The demographic, clinical characteristics and laboratory findings of the study group (n = 33, mean age 48 ± 12 years, 24 men), the responders (n = 12, mean age 47 ± 9 years, 8 men) and the control group (n = 11, mean age 51 ± 12 years, 8 men) are listed in Table 1. No abnormal findings were noticed in chest X-ray, electrocardiogram and left ventricular systolic function after echocardiograph. All patients were classified as NYHA class I without symptoms of diastolic dysfunction. No differences were found

Discussion

Decades ago, non-randomized studies showed that surgical sympathectomy was an effective treatment for some patients with uncontrolled hypertension, but profound postural hypotension along with increased morbidity and mortality rates occurred after the procedure, therefore it was abandoned [13]. In our days, the first successful results from renal denervation (RDN) studies shifted interest back to the old perception of sympathetic nervous system (SNS) over activation as a pathophysiological

Study limitations

Our study has a number of limitations which should be recognized. The number of patients overall and in each study group (study group, responders and control group) is low. The high prevalence of arterial hypertension in the population requires a greater number of patients in order to generalize the results of the study in untreated hypertensives, treated hypertensives on different medications or patients with severe hypertension due to activated SNS (i.e. chronic kidney disease population) [50]

Conclusions

Our results indicate that SPG block might be a promising, non invasive, safe, painless and easy to perform therapeutic option of arterial hypertension without any subsequent complications. It resembles to RDN as to the need of a bilateral application and the unknown immediate effect since no drop in blood pressure is seen just after the procedure. However, as SPG block just causes an anesthetic effect instead of destroying the nerve fibers, a lot of questions emerge regarding the long term

References (50)

  • Z. Wang et al.

    Degenerative pathological irritations to cervical PLL may play a role in presenting sympathetic symptoms

    Med. Hypotheses

    (2011)
  • M.P. Schlaich et al.

    International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension

    JACC

    (2013)
  • G. Mancia et al.

    ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    Eur. Heart J.

    (2013)
  • G.F. DiBona

    The sympathetic nervous system and hypertension: recent developments

    Hypertension

    (2004)
  • F. Mahfoud et al.

    Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future

    Eur Heart J.

    (2017; May5)
  • G. Sluder

    The role of the sphenopalatine ganglion in nasal headache

    NY State J Med.

    (1908)
  • S. Waldman

    Sphenopalatine ganglion block — 80 years later

    Reg. Anesth.

    (1993)
  • S.N. Narouze

    Interventional Management of Head and Face Pain. Nerve Blocks and Beyond

    (2014)
  • M. Piagkou et al.

    The pterygopalatine ganglion and its role in various pain syndromes: from anatomy to clinical practice

    Pain Pract

    (2012)
  • S. Siéssere et al.

    Anatomic variation of cranial parasympathetic ganglia

    Braz Oral Res.

    (2008)
  • H. Triantafyllidi et al.

    Is arterial hypertension control enough to improve aortic stiffness in untreated patients with hypertension? A 3-year follow-up study

    Angiology

    (2015)
  • R. Devereux et al.

    Echocardiographic assessment of left ventricular mass in man

    Circulation

    (1977)
  • C.P. Newcombe et al.

    Sympathectomy for hypertension; follow-up of 212 patients

    Br. Med. J.

    (1959)
  • M.D. Esler et al.

    The Symplicity HTN-2 investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial

    Lancet

    (2010)
  • D.L. Bhatt et al.

    SYMPLICITY HTN-3 investigators. A controlled trial of renal denervation for resistant hypertension

    N. Engl. J. Med.

    (2014)
  • Cited by (7)

    • Effect of sphenopalatine ganglion block on intracranial pressure and cerebral venous outflow oxygenation during craniotomy for supratentorial brain tumours

      2022, Anaesthesia Critical Care and Pain Medicine
      Citation Excerpt :

      SPGB has a unique effect compared with other brain dehydrating measures considering that it affects only the cerebral circulation without any effect on the systemic circulation. However, Triantafyllidi et al. [35] showed that the decrease in blood pressure in their studied patients, who had uncontrolled hypertension, was ≥ 5 mmHg within 24 h. These results indicate that there was no acute onset of the haemodynamic response to the block.

    • Interventional Pain Management Procedures

      2020, Pain Management for Clinicians: A Guide to Assessment and Treatment
    View all citing articles on Scopus

    The authors report no relationships that could be construed as a conflict of interest.

    View full text